Announced Wed, 7 Oct, 2026 · 14:36 IST
Quarterly compliance certificate for dematerialization of shares filed
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.7%1-day move
₹22.55
prior close
₹22.47
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.0-0.0-0.1-1.7—————————
Up moveDown movePending
AI summary
Balaxi Pharmaceuticals submitted a certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The certificate, issued by its Registrar and Share Transfer Agent Aarthi Consultants Pvt Ltd, confirms that physical share certificates received from depository participants were mutilated and cancelled, and the depository's name was recorded as the registered owner within the required 15 days. The filing is a routine compliance requirement with no material business impact.
Likely market impact
Routine regulatory compliance filing; no impact on shareholders or the stock.